Herbalife Ltd. (NYSE:HLF) Director Juan Miguel Mendoza Buys 16,079 Shares of Stock

Herbalife Ltd. (NYSE:HLF) Director Juan Miguel Mendoza acquired 16,079 shares of the company’s stock in a transaction that occurred on Tuesday, March 26th. The shares were acquired at an average cost of $9.40 per share, with a total value of $151,142.60. Following the purchase, the director now directly owns 54,622 shares of the company’s stock, valued at approximately $513,446.80. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website.

Herbalife Price Performance

Shares of NYSE:HLF opened at $9.48 on Thursday. Herbalife Ltd. has a 1 year low of $6.68 and a 1 year high of $19.48. The company has a market cap of $945.51 million, a PE ratio of 6.67 and a beta of 1.21. The stock’s 50-day moving average is $10.12 and its 200 day moving average is $12.56.

Herbalife (NYSE:HLF) last announced its quarterly earnings results on Wednesday, February 14th. The company reported $0.28 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.38 by ($0.10). Herbalife had a net margin of 2.81% and a negative return on equity of 19.56%. The business had revenue of $1.20 billion for the quarter, compared to analysts’ expectations of $1.19 billion. During the same quarter in the prior year, the firm earned $0.53 EPS. The firm’s revenue for the quarter was up .0% on a year-over-year basis. Analysts expect that Herbalife Ltd. will post 1.8 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

Several equities research analysts have issued reports on the company. Mizuho dropped their price target on Herbalife from $12.00 to $10.00 and set a “neutral” rating for the company in a research note on Thursday, March 21st. Bank of America lowered their target price on Herbalife from $10.00 to $8.00 and set an “underperform” rating for the company in a research note on Thursday, March 21st. DA Davidson lowered their target price on Herbalife from $11.00 to $9.50 and set a “neutral” rating for the company in a research note on Monday. Finally, StockNews.com raised Herbalife from a “hold” rating to a “buy” rating in a research note on Friday, February 16th. One research analyst has rated the stock with a sell rating, four have assigned a hold rating and one has given a buy rating to the company’s stock. Based on data from MarketBeat, the stock presently has an average rating of “Hold” and a consensus target price of $10.50.

Institutional Inflows and Outflows

A number of hedge funds have recently bought and sold shares of the business. Nomura Asset Management Co. Ltd. grew its holdings in shares of Herbalife by 150.0% during the 1st quarter. Nomura Asset Management Co. Ltd. now owns 1,900 shares of the company’s stock worth $31,000 after acquiring an additional 1,140 shares during the period. Advisor Group Holdings Inc. grew its stake in shares of Herbalife by 50.0% in the 1st quarter. Advisor Group Holdings Inc. now owns 4,243 shares of the company’s stock worth $128,000 after buying an additional 1,415 shares during the last quarter. Lazard Asset Management LLC purchased a new stake in shares of Herbalife in the 3rd quarter worth approximately $66,000. Point72 Middle East FZE purchased a new stake in shares of Herbalife in the 4th quarter worth approximately $121,000. Finally, Ameritas Investment Partners Inc. grew its stake in shares of Herbalife by 9.9% in the 2nd quarter. Ameritas Investment Partners Inc. now owns 8,166 shares of the company’s stock worth $108,000 after buying an additional 736 shares during the last quarter.

About Herbalife

Herbalife Ltd. provides health and wellness products in North America, Mexico, South and Central America, Europe, the Middle East, Africa, China, and the Asia Pacific. It offers products in the areas of weight management; targeted nutrition; energy, sports, and fitness; outer nutrition; and literature and promotional items.